Gastrointestinal carcinoid tumors: A multi-technique diagnostic approach;Tumeurs endocrines digestives: Stratégie diagnostique

Journal de Chirurgie

Volumn 144, Issue 4, 2007, Pages 287-292

  Mathonnet, M ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

5 HIAA; Chromogranin A; Endoscopy; Fusion imaging; Gastrointestinal carcinoid; MEN; Neuroendocrine tumor; Octreoscan; Positron emission tomography; Scintigraphy; Serotonin

Indexed keywords

EID: 35348816210     PISSN: 00217697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-7697(07)91954-7     Document Type: Article

References (26)

1. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13715 carcinoid tumors. Cancer 2003;97:934-959.
2. Larsen WJ, Embryologie humaine. Bruxelles : DeBoeck Université ; 1996.
3. Brunaud L, Bresler L, Ayav A et al. Prise en charge chirurgicale des tumeurs endocrines du tractus gastro-intestinal. Ann Chir 2004;129:563-570.
4. Kema IP, de Vries EG, Slooff MJ, Biesma B, Muskiet FA. Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with cvarcinoid tumors. Clin Chem 1994;40:86-95.
5. Baudin E, Degorce F. Méthodologie et utilisation du dosage de la chromogranine A en biologie clinique. Medecine/Sciences 2001;17:438-447.
6. Zuetenhorst JM, Taal BG. Metastatic carcinoid tumors: a clinical review. Oncologist 2005;10:123-131.
7. Carling RS, Degg TJ, Allen KR, Bax ND, Barth JH. Evaluation of whole blood serotonin and plasma and urine 5 hydroxyindole acetic acid in diagnosis of carcinoid disease. Ann Clin Biochem 2002;39:577-582.
8. Patel YC. Molecular pharmacology of somatostatin receptor subtypes. J Endocrinol Invest 1997;20:348-367.
9. de Herder WW, Hofland LJ, van der Lely AJ, Lamberts SW. Somatostatin receptors in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 2003;10:451-458.
10. Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocrine Reviews 2004;25:458-511.
11. Modlin IM, Latich I, Zikusoka M, Kidd M, Eick G, Chan AK. Gastrointestinal carcinoids: the evolution of diagnostic strategies. J Clin Gastroenterol 2006;40:572-582.
12. Panzuto F, Falconi M, Nasoni S et al. Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy. Ann Oncol 2003;14:586-591.
13. Benevento A, Dominioni L, Carcano G, Dionigi R. Intraoperative localization of gut endocrine tumors with radiolabeled somatostatin analogs and a gamma-detecting probe. Semin Surg Oncol 1998;15:239-244.
14. Hoefnagel CA, den Hartog Jager FC, Taal BG, Abeling NG, Engelsman EE. The role of I-123-MIBG in the diagnosis and therapy of carcinoids. Eur J Nucl Med 1987;13:187-191.
15. Kaltsas G, Korbonits M, Heintz E et al. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides an the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 2001;86:895-902.
16. 111In- pentetreotide in carcinoid tumours. Eur J Cancer 1996;32:1924-1932.
17. Pasquali C, Rubello D, Sperti C et al. Neuroendocrine tumor imaging: can 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior? World J Surg 1998;22:588-592.
18. Orlefors H, Sundin A, Garske U et al. Whole-body (11)C-5-hydroxytryptophanepositron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab 2005;90:3392-3400.
19. Hoegerle S, Altehoefer C, Ghanem N et al. Whole-body 18F Dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 2001;220:373-380.
20. Waldherr C, Pless M, Maecke HR, Haldemann A, Müller-Brand J. The c linical value of (90Y-DOTA)-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study. Ann Oncol 2001;12:941-945.
21. Gore RM, Berlin JW, Mehta UK, Newmark GM, Yaghmai V. GI carcinoid tumours: appearance of the primary and detecting metastases. Best Pract Res Clin Endocrinol Metab 2005;19:245-263.
22. Horton KM, Kamel I, Hofmann L, Fishman E. Carcinoid tumors of the small bowel: a multitechnique imaging approach. Am J Radiol 2004;182:559-567.
23. Ohrvall U, Eriksson B, Juhlin C et al. Method for dissection of mesenteric metastases in midgut carcinoid tumors. World J Surg 2000;24:1402-1408.
24. Caplin ME, Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs AK. Carcinoid tumour. Lancet 1998;352:799-805.
25. deMascarenhas-Saraiva MN, da Silva Araujo Lopes LM. Small-bowel tumors diagnosed by wireless capsule endoscopy: report of five cases. Endoscopy 2003;35:865-868.
26. Van Tuyl SAC, Tenthof van Noorden J, Timmer R, Stolk MFJ, Kuipers EJ, Taal BG. Detection of small-bowel neuroendocrine tumors by video capsule endoscopy. Gastrointest Endosc 2006;64:66-72.